Business Trends– category –
-
Argo Graphene Solutions Secures Grapherry’s STREAM Technology, Accelerating Path to Scalable Graphene Commercialization
Newsfile (Argo Graphene Solutions Corp.発表) Canada Overview Argo Graphene Solutions Corp. has entered a licensing and technology transfer agreement with Grapherry, Inc. for its proprietary STREAM graphene production platform. This strat... -
GMG Scales Graphene Production and Accelerates Groundbreaking G+AI Battery Commercialization
OTC Markets (Graphene Manufacturing Group Ltd.発表) Australia Overview Graphene Manufacturing Group Ltd. (GMG) has secured a new facility to significantly expand its graphene production and operational capabilities, a strategic move to b... -
Black Swan Graphene Expands UK Production to 140+ Tonnes, Acquires Falpaco to Bolster Commercialization
Black Swan Graphene Inc. (via Reddit) Canada Overview Black Swan Graphene Inc. has significantly expanded its UK graphene production capacity from 40 to over 140 tonnes annually using a custom GEA Group AG Ariete system, accelerating its... -
Overcoming Translational Hurdles: Nanotechnology Paves Way for Advanced Cancer Immunotherapies
MDPI Switzerland Overview Nanotechnology offers significant potential in developing highly effective cancer vaccines by enhancing tumor-specific immune responses. Diverse nanoparticle platforms, including liposomes, polymers, inorganic n... -
Europe’s Biotech Vanguard: Ori Biotech’s Modular Automation Reshapes Cell and Gene Therapy Manufacturing
PharmTech ヨーロッパ Overview European biotechnology firms are pioneering advanced manufacturing solutions to overcome critical production hurdles in cell and gene therapies. Ori Biotech, in strategic collaborations with Cell Therapies, ... -
Cynata Therapeutics Anticipates Announcing iPSC-MSC Clinical Results for Knee Osteoarthritis Phase 3 and Acute GvHD Phase 2 Trials Soon
Regen Report Australia Overview Australian cell therapy company Cynata Therapeutics has announced it will release results from two pivotal clinical trials using its iPSC-derived mesenchymal stem cells (iPSC-MSC) within months. These incl... -
Sana Biotechnology Reports 14-Month Positive Clinical Results for Immunosuppression-Free iPSC-Derived Islet Cell Transplant in Type 1 Diabetes
Simply Wall St (via Nasdaq:SANA) USA Overview Sana Biotechnology announced continued positive clinical results from its study of iPSC-derived islet cell transplantation (UP421) for Type 1 diabetes, spanning 14 months without immunosuppre... -
FUJIFILM Cellular Dynamics Quadruples iPSC Manufacturing Capacity with $200M New Facility in Wisconsin, Meeting Soaring Cell Therapy Demand
Manufacturing Dive USA Overview FUJIFILM Cellular Dynamics (FCDI) has inaugurated a new headquarters and iPSC development and manufacturing facility in Madison, Wisconsin, backed by a $200 million investment. This 170,000 square-foot exp... -
OMV’s ReOil®: Engineering High-Quality Circularity for Critical Plastic Applications
OMV.com オーストリア Overview Austrian energy and chemical firm OMV continues to advance its proprietary ReOil® chemical recycling technology, a process initiated in 2009 that transforms post-consumer plastic waste into high-quality basi... -
Traceless Inaugurates First Industrial-Scale Plant for Bio-Based, Home-Compostable Polymer
Trend Hunter Germany Overview Traceless has launched its inaugural industrial production facility in Hamburg, Germany, to manufacture 'Traceless Natural Polymer,' a bio-based, home-compostable alternative to fossil-derived plastics. Util...
